MedPath

The Australian Placental Transfusion Study (APTS): Should Very Pre Term Babies Receive a Placental Blood Transfusion at Birth Via Deferring Cord Clamping Versus Standard Cord Clamping Procedures?

Not Applicable
Completed
Conditions
Preterm Birth
Interventions
Procedure: Deferred cord clamping
Registration Number
NCT02606058
Lead Sponsor
University of Sydney
Brief Summary

To establish if placental transfusion, using deferred cord clamping for 60 seconds or more while holding the baby at or below the level of the placenta, will improve survival without disability compared with standard early cord clamping in preterm babies less than 30 weeks of gestation.

Detailed Description

Most preterm babies have the umbilical cord clamped within 10 seconds of birth. Placental transfusion is a simple way of giving the baby extra blood at birth by delaying the clamping of the umbilical cord by 60 seconds or more. There is promising evidence from randomised trials that placental transfusion in babies less than 37 weeks of pregnancy may improve their blood pressure, reduce the number of blood transfusions needed and decrease bleeding into the brain, bowel disease and infection. However, we not know if babies born before 30 weeks of pregnancy benefit or if placental transfusion increases or decreases death or childhood disability. Despite this uncertainty more doctors are recommending that all very preterm babies are given a placental transfusion at birth. It is important to find out if placental transfusion does more good than harm, before it becomes even more widely used.

The Australian Placental Transfusion Study will enrol at least 1600 women who will give birth to babies born less than 30 weeks of gestation. These participants will be randomly assigned to either standard treatment where the umbilical cord is clamped within 10 seconds of birth or a second method where the umbilical cord will be clamped after waiting for 60 seconds or more at birth while the baby is being held below the level of the placenta. The main research question is whether placental transfusion reduces death and disability when the baby is discharged from hospital and into childhood.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
1637
Inclusion Criteria

Women who have a reasonable chance of delivering less than 30 weeks of gestation. Informed consent has been received from the parent or guardian.

Read More
Exclusion Criteria

No indication or contraindication to placental transfusion, in the view of mother or baby.

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Deferred cord clampingDeferred cord clampingDeferred cord clamping. Investigator/Research personnel holds the baby as low as possible below the level of the introitus or placenta for 60 seconds and not to exceed 80 seconds, then clamps the cord about 6 cm from the umbilicus.
Primary Outcome Measures
NameTimeMethod
Death and/or major morbidity at 36 weeks post menstrual age36 weeks post menstrual age

Composite death and/or major morbidity at 36 completed weeks post menstrual age. Morbidity is defined by one or more of the following: brain injury on ultrasound, severe retinopathy, necrotising enterocolitis, late onset sepsis.

Secondary Outcome Measures
NameTimeMethod
IVH (all grades) seen on ultrasound36 completed weeks post menstrual age
IVH (Grades 3 & 4) seen on ultrasound36 completed weeks post menstrual age
Incidence of death or major disabilityUp to 3 years corrected age

Death or major disability (for example cerebral palsy with inability to walk; blindness; deafness; major problems with language or speech; ASQ score indicative of developmental delay)

Incidence of death or brain injury on ultrasound36 completed weeks post menstrual age

Death or brain injury on ultrasound

Incidence of major morbidity36 completed weeks post menstrual age

Major morbidity (incidence of one or more of brain injury on ultrasound, severe retinopathy, necrotising enterocolitis or late onset sepsis).

Major disability defined as cerebral palsy with an inability to walk unassisted, severe visual loss, deafness, major problems with language or speech, or a score indicative of developmental delay on Ages and Stages Questionnaire.Up to 3 years corrected age
Brain injury on ultrasound36 completed weeks post menstrual age
Incidence of death36 completed weeks post menstrual age

The death component of the composite primary outcome

IVH (Grade 4) seen on ultrasound36 completed weeks post menstrual age
Severe retinopathy warranting treatment or Stage 4 retinopathy according to the Australian and New Zealand Neonatal Network (ANZNN) definitions36 completed weeks post menstrual age
Necrotizing enterocolitis with the following signs: at least 1 systemic sign, profile consistent with definite NEC, warranted treatment for NEC.36 completed weeks post menstrual age
Patent ductus arteriosis requiring treatment (documented in medical records)36 completed weeks post menstrual age
Chronic lung disease, defined as receiving supplemental oxygen or any form of assisted ventilation at 36 completed weeks post menstrual age for 4 consecutive hours in a 24 hour period36 completed weeks post menstrual age
Death up to 3 years corrected ageUp to 3 years corrected age
Late onset sepsis, defined as a clinical picture consistent with sepsis, and either a positive culture of blood and/or CSF, or a positive urine culture by sterile collection, and at least 5 days of antibiotic treatment.36 completed weeks post menstrual age

Trial Locations

Locations (26)

University of Vermont Medical Centre

๐Ÿ‡บ๐Ÿ‡ธ

Burlington, Vermont, United States

Royal Hospital for Women

๐Ÿ‡ฆ๐Ÿ‡บ

Sydney, New South Wales, Australia

Baylor College of Medicine

๐Ÿ‡บ๐Ÿ‡ธ

Houston, Texas, United States

Liverpool Hospital

๐Ÿ‡ฆ๐Ÿ‡บ

Sydney, New South Wales, Australia

Canberra Hospital

๐Ÿ‡ฆ๐Ÿ‡บ

Canberra, Australian Capital Territory, Australia

John Hunter Hospital

๐Ÿ‡ฆ๐Ÿ‡บ

Newcastle, New South Wales, Australia

Royal North Shore Hospital

๐Ÿ‡ฆ๐Ÿ‡บ

Sydney, New South Wales, Australia

Royal Prince Alfred Hospital

๐Ÿ‡ฆ๐Ÿ‡บ

Sydney, New South Wales, Australia

Mater Mother's Hospital

๐Ÿ‡ฆ๐Ÿ‡บ

Brisbane, Queensland, Australia

Nepean Hospital

๐Ÿ‡ฆ๐Ÿ‡บ

Sydney, New South Wales, Australia

Royal Brisbane and Women's Hospital

๐Ÿ‡ฆ๐Ÿ‡บ

Brisbane, Queensland, Australia

Townsville Hospital

๐Ÿ‡ฆ๐Ÿ‡บ

Townsville, Queensland, Australia

Flinders Medical Centre

๐Ÿ‡ฆ๐Ÿ‡บ

Adelaide, South Australia, Australia

Hรดpital Antoine-Bรฉclรจre

๐Ÿ‡ซ๐Ÿ‡ท

Clamart, France

IWK Health Center

๐Ÿ‡จ๐Ÿ‡ฆ

Halifax, Nova Scotia, Canada

Christchurch Hospital

๐Ÿ‡ณ๐Ÿ‡ฟ

Christchurch, New Zealand

Auckland Hospital

๐Ÿ‡ณ๐Ÿ‡ฟ

Auckland, New Zealand

Waikato Hospital

๐Ÿ‡ณ๐Ÿ‡ฟ

Hamilton, New Zealand

Dunedin Hospital

๐Ÿ‡ณ๐Ÿ‡ฟ

Dunedin, New Zealand

Wellington Hospital

๐Ÿ‡ณ๐Ÿ‡ฟ

Wellington, New Zealand

Craigavon Area Hospital

๐Ÿ‡ฌ๐Ÿ‡ง

Craigavon, Northern Ireland, United Kingdom

Royal Jubilee Maternity Hospital

๐Ÿ‡ฌ๐Ÿ‡ง

Belfast, Northern Ireland, United Kingdom

King Edward Memorial Hospital

๐Ÿ‡ฆ๐Ÿ‡บ

Perth, Western Australia, Australia

Mercy Hospital for Women

๐Ÿ‡ฆ๐Ÿ‡บ

Melbourne, Victoria, Australia

Aga Khan University Hospital

๐Ÿ‡ต๐Ÿ‡ฐ

Karachi, Pakistan

Monash Medical Centre

๐Ÿ‡ฆ๐Ÿ‡บ

Melbourne, Victoria, Australia

ยฉ Copyright 2025. All Rights Reserved by MedPath